Product Information
MINOCYCLINE 75 MG CAPSULE is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.4304 per EA under NDC 68382031701. Its NADAC has been published 470 times since Jun 28, 2017.
Strength
75 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382031701
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MINOCYCLINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA063009On Market Since
4/3/2017
Pharmacological Classes
Price Statistics
The NADAC for MINOCYCLINE 75 MG CAPSULE has been published 470 times since Jun 28, 2017, and over the history we have for it it has declined 8.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4304 per EA |
|---|---|
| All-time high | $0.5390 (May 16, 2018) |
| All-time low | $0.2639 (Feb 19, 2025) |
| 52-week high | $0.4410 |
| 52-week low | $0.3384 |
| Median price | $0.4066 |
| Average price | $0.4023 |
| Largest weekly change | +31.6% (Mar 20, 2024) |
| Weeks tracked | 470 |
| Tracking since | Jun 28, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Minocycline hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of MINOCYCLINE 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MINOCYCLINE 75 MG CAPSULE, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.4304 per EA (NDC 68382031701), effective Jun 24, 2026.
How has the price of MINOCYCLINE 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MINOCYCLINE 75 MG CAPSULE has declined 8.2%. It has been tracked across 470 weekly CMS publications since Jun 28, 2017.
What are the highest and lowest recorded NADAC prices for MINOCYCLINE 75 MG CAPSULE?
Since Jun 28, 2017, the NADAC for MINOCYCLINE 75 MG CAPSULE has ranged from a low of $0.2639 (Feb 19, 2025) to a high of $0.5390 (May 16, 2018), with a median of $0.4066 per EA.
Are there cheaper alternatives to MINOCYCLINE 75 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of MINOCYCLINE 75 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures MINOCYCLINE 75 MG CAPSULE?
MINOCYCLINE 75 MG CAPSULE (NDC 68382031701) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification